PTEN knock-down decreases the ability of T cells to kill tumour cells through the indirect activation of STAT3, a transcription factor that is a key signalling node and a regulator of the critical hallmarks of cancer, tumour angiogenesis, resistance to apoptosis, metastasis, and immune evasion [34]. The gene discussed is PTEN; the disease is cancer.